Sotera Health (SHC) revenue breakdown
By segment, Sterigenics is the largest at 65% of fiscal 2025 revenue; Nordion grew fastest, 8% a year over 6 years.
By product, Service is the largest at 86% of fiscal 2025 revenue; Product grew fastest, 8% a year over 6 years.
Revenue by segment
Fiscal years, as Sotera Health reports them in its 10-K filings; fiscal 2025 total $1.2B.
| Segments | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|
| Sterigenics | $472M | $499M | $572M | $627M | $667M | $698M | $756M | 65% |
| Nelson Labs | $190M | $205M | $219M | $223M | $222M | $229M | $220M | 19% |
| Nordion | $116M | $115M | $141M | $154M | $160M | $173M | $188M | 16% |
Revenue by product
Fiscal years, as Sotera Health reports them in its 10-K filings; fiscal 2025 total $1.2B.
| Products | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|
| Service | $673M | $714M | $806M | $865M | $906M | $942M | $996M | 86% |
| Product | $105M | $105M | $126M | $139M | $144M | $159M | $168M | 14% |
Revenue by region
Fiscal years, as Sotera Health reports them in its 10-K filings; fiscal 2025 total $1.2B.
| Regions | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|
| United States | $474M | $490M | $528M | $579M | $591M | $617M | $630M | 54% |
| Europe | $123M | $136M | $162M | $166M | $188M | $196M | $232M | 20% |
| Canada | $130M | $136M | $178M | $189M | $192M | $209M | $222M | 19% |
| Other | $51M | $56M | $64M | $70M | $79M | $79M | $80M | 7% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for SHC.
Open SHC in InvestinglyQuestions
Where does Sotera Health make its money?
In fiscal 2025, by segment: Sterigenics $756M, Nelson Labs $220M, Nordion $188M.
From Sotera Health's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.